Created by potrace 1.16, written by Peter Selinger 2001-2019

beatandraise

beta

Latest Financials

Filings:

By CategoryBy DateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

Company Exhibits:

IndenturesMaterial Contracts & Credit AgreementsPlans of ReorganizationArticles and BylawsUnderwriting Agreements

SEC Edgar

NEOGEN CORP

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019

beatandraise.com

beta

Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

NEOGEN CORP

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
Created by potrace 1.16, written by Peter Selinger 2001-2019

beatandraise.com

beta

Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

NEOGEN CORP

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
$NEOG

NEOGEN CORP

CIK:0000711377|SEC Filings

ARTICLES AND BYLAWS

EX-3.2
d925387dex32.htm
2020-07-30T00:00:00Z
EX-3.(I)
d262964dex3i.htm
2011-12-30T00:00:00Z
EX-3.1
ny20004078x25_ex3-1.htm
2022-09-01T00:00:00Z
EX-3.2
ny20004078x25_ex3-2.htm
2022-09-01T00:00:00Z
EX-3.1
ny20003153x5_ex3-1.htm
2022-03-17T00:00:00Z
EX-3.1
neog-ex3_1.htm
2023-10-31T00:00:00Z
EX-3.1
EX-3.1.txt
2000-04-14T00:00:00Z
EX-3.2
EX-3.2.txt
2000-04-14T00:00:00Z